Explained: Why conditional approval for Bharat Biotech’s Covaxin is raising questions

The DCGI has said the approval is in “clinical trial mode” but has not clarified this in detail. If an experimental vaccine is given to people, there should be informed consent explaining the potential risks and benefits of the vaccine and post-vaccination follow-up. In case there is any serious adverse reaction, the recipient may also be eligible for compensation.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/explained-why-conditional-approval-for-bharat-biotech’s-covaxin-is-raising-questions_14634361.html